AI-generated summary
The authors report a non-randomised pilot study of 50 adults with bilateral intermediate age-related macular degeneration who received ultra-low energy nanosecond laser to one eye. Treatment was painless without visible lesions, drusen area reduced in some eyes, and flicker sensitivity improved in both treated and untreated eyes at 3 months. The authors say the laser warrants ongoing evaluation.
- Participants
- 50
- Who or what was studied
- Adults aged 50-75 years with bilateral intermediate age-related macular degeneration
- Wavelengths
- 532 nm
- Limits stated in the abstract
- The study was a prospective non-randomised pilot without a control group, so the results cannot establish causation.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 532 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Age-related macular degeneration, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.